Li Ka-shing

Kimia Therapeutics Raises $55 Million Series A

Retrieved on: 
Tuesday, December 19, 2023

BERKELEY, Calif., Dec. 19, 2023 (GLOBE NEWSWIRE) --  Kimia Therapeutics, Inc. (Kimia), a biotechnology company generating a chemical atlas for treating human disease, today announced that it has closed a $55 million Series A financing. The Column Group and Dimension led the Series A round and was joined by Horizons Ventures and individual investors. The funding will enable Kimia to expand its ATLAS platform and pursue a broad range of therapeutic targets in oncology, immunology and inflammation while continuing to partner with Carmot Therapeutics Inc. (Carmot) on key metabolic programs.

Key Points: 
  • – Kimia is advancing its ATLAS platform that combines high-throughput chemistry with chemical biology, genome editing and machine learning to create a chemical map of the druggable proteome and accelerate the discovery of novel therapeutics targets and drug leads –
    BERKELEY, Calif., Dec. 19, 2023 (GLOBE NEWSWIRE) --  Kimia Therapeutics, Inc. (Kimia), a biotechnology company generating a chemical atlas for treating human disease, today announced that it has closed a $55 million Series A financing.
  • The Column Group and Dimension led the Series A round and was joined by Horizons Ventures and individual investors.
  • Kimia is building a next generation therapeutics discovery platform called ATLAS that combines AcTive Learning with Automated Synthesis and screening.
  • ATLAS is powered by a high-throughput, nano-liter scale chemistry platform that provides Kimia with instant access to billions of drug-like compounds.

FIII HONG KONG INVESTOR SUMMIT 7/8 DECEMBER BRINGS LEADERS TOGETHER TO ADDRESS HUMANITY'S BIGGEST CHALLENGES

Retrieved on: 
Friday, December 8, 2023

Investors and leaders from across Asia have gathered in Hong Kong with counterparts from around the world at an international summit to address global challenges, and the mobilisation of investment as a force for good.

Key Points: 
  • Investors and leaders from across Asia have gathered in Hong Kong with counterparts from around the world at an international summit to address global challenges, and the mobilisation of investment as a force for good.
  • John Lee, Chief Executive, Hong Kong Special Administrative Region, welcomed the FII Institute to Hong Kong in the presence of Paul Chan, Financial Secretary, and Laura M Cha, Chairman of Hong Kong Exchanges and Clearing Limited (HKEX).
  • The summit, held in partnership with Hong Kong Exchanges and Clearing Limited (HKEX), is taking place at HKEX Connect Hall today, Thursday 7 December and tomorrow, Friday 8 December 2023.
  • Nicholas Ho, Commissioner for Belt & Road, The Government of the Hong Kong Special Administrative Region described Hong Kong as a "true global hub" and outlined his vision to strengthen Hong Kong as the regional headquarter for MENA region business.

FIII HONG KONG INVESTOR SUMMIT 7/8 DECEMBER BRINGS LEADERS TOGETHER TO ADDRESS HUMANITY'S BIGGEST CHALLENGES

Retrieved on: 
Friday, December 8, 2023

Investors and leaders from across Asia have gathered in Hong Kong with counterparts from around the world at an international summit to address global challenges, and the mobilisation of investment as a force for good.

Key Points: 
  • Investors and leaders from across Asia have gathered in Hong Kong with counterparts from around the world at an international summit to address global challenges, and the mobilisation of investment as a force for good.
  • John Lee, Chief Executive, Hong Kong Special Administrative Region, welcomed the FII Institute to Hong Kong in the presence of Paul Chan, Financial Secretary, and Laura M Cha, Chairman of Hong Kong Exchanges and Clearing Limited (HKEX).
  • The summit, held in partnership with Hong Kong Exchanges and Clearing Limited (HKEX), is taking place at HKEX Connect Hall today, Thursday 7 December and tomorrow, Friday 8 December 2023.
  • Nicholas Ho, Commissioner for Belt & Road, The Government of the Hong Kong Special Administrative Region described Hong Kong as a "true global hub" and outlined his vision to strengthen Hong Kong as the regional headquarter for MENA region business.

ZeroAvia announces completion of $116m Series C funding round

Retrieved on: 
Monday, November 27, 2023

KEMBLE, England and HOLLISTER, Calif., Nov. 27, 2023 /PRNewswire/ -- ZeroAvia today announced that it has completed its Series C funding round at a total of $116m.

Key Points: 
  • KEMBLE, England and HOLLISTER, Calif., Nov. 27, 2023 /PRNewswire/ -- ZeroAvia today announced that it has completed its Series C funding round at a total of $116m.
  • The financing supports the UK's status as a market leader in research and development in both aviation and hydrogen and will support ZeroAvia's ambitious growth plans in the UK.
  • This funding raise will help support the Government's target to decarbonise aviation by 2050 by developing new clean propulsion technologies that can be flying between UK airports this decade.
  • Breakthrough Energy Ventures, Horizons Ventures, Alaska Airlines, Ecosystem Integrity Fund, Summa Equity, AP Ventures and Amazon Climate Pledge Fund have also participated in the funding round.

HEALWELL AI Makes Investment and Launches Strategic Alliance with ‘doctorly’ to Bring HEALWELL’s Clinical Decision Support to European Market

Retrieved on: 
Thursday, November 9, 2023

HEALWELL has also entered into a strategic alliance agreement with doctorly which provides HEALWELL with access to doctorly’s rapidly growing healthcare provider base and facilitates healthcare provider onboarding onto HEALWELL’s clinical decision support platform.

Key Points: 
  • HEALWELL has also entered into a strategic alliance agreement with doctorly which provides HEALWELL with access to doctorly’s rapidly growing healthcare provider base and facilitates healthcare provider onboarding onto HEALWELL’s clinical decision support platform.
  • Germany is Europe’s largest healthcare market and is an important jurisdiction for healthcare innovation and commercial opportunity for HEALWELL’s expansion plans.
  • Earlier this year WELL Health Technologies Corp., HEALWELL’s largest shareholder, co-invested with its strategic investor Horizon Ventures into doctorly.
  • In addition, Germany is second in the world in healthcare consumption expenditures per capita, trailing only the United States(2).

Evolv AI Raises $13.3M to Fuel Enhanced Generative AI Capabilities

Retrieved on: 
Thursday, November 9, 2023

SAN FRANCISCO, Nov. 9, 2023 /PRNewswire/ -- Evolv AI, the maker of the world's leading intelligent digital experience optimization and personalization platform, today announced the closing and conversion of their previously issued convertible notes and a new equity round, for a total of $13.3 million in new funding. Led by Horizons Ventures, the round brings their total funding to date to $23.3M. New and existing investors like Horizons Ventures, NJF Capital, Engage VC, Major Group Asia, and others participated in the round.

Key Points: 
  • "This new investment will allow Evolv AI to grow its go-to-market capabilities, reach more customers, and accelerate the development of the company's groundbreaking AI platform," said Michael Scharff, co-founder of Evolv AI.
  • "This news comes after Evolv AI added market-leading generative AI capabilities to its product, allowing customers to use the power of AI all within one platform."
  • Brands like Verizon, Lululemon, and DirectTV have partnered with Evolv AI to support their AI initiatives.
  • All of the generative AI features launched this summer are now available to Evolv AI customers who value experimentation and testing as integral to building exceptional digital experiences and seek to capitalize on the massive opportunity that AI provides.

Promise Robotics Raises USD$15 Million Series A to Enable the Homebuilding Industry to Close the Housing Gap at Scale

Retrieved on: 
Tuesday, October 31, 2023

TORONTO, Oct. 31, 2023 /PRNewswire/ -- Promise Robotics, an AI company developing a cloud-based industrial production platform for robotic construction and assembly, today announced it raised USD$15 million in Series A funding, bringing its total funding raised to date to USD$25 million. This round was led by Horizons Ventures with participation from Radical Ventures, Public Sector Pension Investment Board (PSP Investments), and strategic investors, including United Brotherhood of Carpenters, Relay Ventures, and Alate Partners. The new funding will help Promise Robotics commercialize its robotic factory platform to support its growing demand from homebuilders and to continue expanding  

Key Points: 
  • To bridge this gap, new home building rates would need to triple - a near-impossible feat with traditional construction technology.
  • Promise Robotics AI-driven system enables the homebuilding industry to deploy automation at scale to address labor shortages, save costs, and significantly increase the speed of sustainable home production from custom single-family to multi-story buildings.
  • To enable the homebuilding industry, Promise Robotics' robotic system aims to remove the risk for homebuilders by offering products that benefit from a decade of operational excellence, continuous improvement, and successful homebuilding.
  • Promise Robotics is well-positioned to be a disruptive force in this industry," said Kerry Liu, an investor at Horizons Ventures.

BioLoomics Raises $8.7 Million Seed Round to Develop Target Degrading Antibodies

Retrieved on: 
Tuesday, September 19, 2023

BioLoomics , the company pioneering directed evolution of target degrading antibodies using human cells, today announced it has raised $8.7 million in seed financing to advance its proprietary platform technology and antibody degrader programs.

Key Points: 
  • BioLoomics , the company pioneering directed evolution of target degrading antibodies using human cells, today announced it has raised $8.7 million in seed financing to advance its proprietary platform technology and antibody degrader programs.
  • He founded BioLoomics to apply principles from the RTA project to overcome market-wide throughput limitations for activity-based discovery of antibodies.
  • “Our mission is to make safer, more effective cancer therapeutics by hijacking how human proteins move antibodies around the cell,” said Dr. Douglas Chapnick, founder and CEO of BioLoomics.
  • With this new capital, BioLoomics will develop pre-clinical assets and form strategic partnerships with large pharma companies.

Airbus, Barclays Sustainable Impact Capital and NEOM co-lead ZeroAvia's latest financing round

Retrieved on: 
Monday, September 18, 2023

KEMBLE, United Kingdom and HOLLISTER, Calif., Sept. 18, 2023 /PRNewswire/ -- ZeroAvia today announced that Airbus, Barclays Sustainable Impact Capital and NEOM have co-led the company's latest financing round. 

Key Points: 
  • KEMBLE, United Kingdom and HOLLISTER, Calif., Sept. 18, 2023 /PRNewswire/ -- ZeroAvia today announced that Airbus , Barclays Sustainable Impact Capital and NEOM have co-led the company's latest financing round.
  • In conjunction with the investment, Airbus and ZeroAvia have agreed to collaborate on certification approaches for hydrogen power systems.
  • ZeroAvia is pursuing hydrogen-electric propulsion systems as the most environmentally friendly and economically attractive solution to aviation's growing climate change impact.
  • Majid Mufti, Managing Director NEOM Investment Fund, said: "At NEOM, we are committed to identifying and implementing sustainable solutions that pave the way for a greener future.

Inflection AI Announces $1.3 Billion of Funding Led by Current Investors, Microsoft, and NVIDIA

Retrieved on: 
Thursday, June 29, 2023

Inflection AI today announced that the company has raised $1.3 billion in a fresh round of funding led by Microsoft, Reid Hoffman, Bill Gates, Eric Schmidt, and new investor NVIDIA.

Key Points: 
  • Inflection AI today announced that the company has raised $1.3 billion in a fresh round of funding led by Microsoft, Reid Hoffman, Bill Gates, Eric Schmidt, and new investor NVIDIA.
  • View the full release here: https://www.businesswire.com/news/home/20230629810313/en/
    Mustafa Suleyman, co-founder and CEO, Inflection AI.
  • (Photo: Business Wire)
    Along with its partners CoreWeave and NVIDIA, Inflection AI is building the largest AI cluster in the world comprising 22,000 NVIDIA H100 Tensor Core GPUs.
  • “The world-class team at Inflection AI is helping to lead this groundbreaking work, deploying NVIDIA AI technology to develop, train and deploy massive generative AI models that enable amazing personal digital assistants.”
    “We’re proud to support Inflection AI as they pursue their vision for more trusted and personal AI experiences,” said Kevin Scott, CTO and EVP AI, Microsoft.